Case Report: Entamoeba Histolytica and Candida Impair Artemisinin-Based Combination Therapy Effect in Malaria Patient

Simple item page
dc.contributor.authorMosab Nouraldein Mohammed Hamad
dc.date.accessioned2023-12-29T05:15:30Z
dc.date.available2023-12-29T05:15:30Z
dc.date.issued2023-12-28
dc.description.abstractMalaria is an endemic disease in Sudan, and the emergence of antimalarial drugs resistance represent a serious problem affecting the Sudanese population. Acidity reduces absorption of antimalarial drugs and allows for malaria parasites to survive and multiply. Enteric pathogens such as Entamoeba histolytica, candida and Helicobacter pylori may support the growth of Plasmodium falciparum, through inhibition of the absorption of antimalarial agent, such as artemisinin-based combination therapy (ACT)
dc.identifier.citationMosab Nouraldein Mohammed Hamad (2023). Case Report: Entamoeba Histolytica and Candida Impair Artemisinin-Based Combination Therapy Effect in Malaria Patient. SAR J Pathol Microbiol, 4(6), 93-94.
dc.identifier.otherDOI: 10.36346/sarjpm.2023.v04i06.008
dc.identifier.urihttps://ds.eaeu.edu.sd/handle/10.58971/976
dc.language.isoen
dc.publisherSAR publisher
dc.titleCase Report: Entamoeba Histolytica and Candida Impair Artemisinin-Based Combination Therapy Effect in Malaria Patient
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
SARJPM_46_93-94.pdf
Size:
121.2 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
open access articles